Skip to content
MarketScale
‹ Back to IndustriesSciences

Chemists Advance Sustainable Battery Technology

Utah State University (USU) chemists are successfully advancing battery technology with a new molecular design for aqueous organic redox flow batteries (AORFB) that could create a new large-scale renewable energy source. The race to develop new, reliable battery technology, along with wind and solar power, is occurring world-wide on many fronts. USU’s battery study is…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences ·
Share
Chemists Advance Sustainable Battery Technology

Key takeaways

01

Utah State University (USU) chemists are successfully advancing battery technology with a new molecular design for aqueous organic redox flow batteries (AORFB) that could create a new large-scale renewable energy source.

02

The race to develop new, reliable battery technology, along with wind and solar power, is occurring world-wide on many fronts.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Utah State University (USU) chemists are successfully advancing battery technology with a new molecular design for aqueous organic redox flow batteries (AORFB) that could create a new large-scale renewable energy source.

The race to develop new, reliable battery technology, along with wind and solar power, is occurring world-wide on many fronts. USU’s battery study is scientifically notable, according to the chemists involved in the project.

First, the battery utilizes a unique two-electron structure that allows the use of abundant available organic materials including nitrogen and hydrogen. Secondly, the battery produces an impressive 1.44 volts of energy in an aqueous electrolyte while maintaining significant energy efficiency and capacity retention.

Traditional battery technologies can be cumbersome and unstable, so USU’s effort will be enthusiastically welcomed by the renewable energy community if the project continues to progress.

Read more at ScienceDaily

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Pharmaceutical companies are increasingly using telehealth digital waiting rooms as prime advertising slots. These virtual spaces offer unique opportunities for pharma brands to engage patients before and after their virtual care visits. The trend is driven by fresh data on patient attention and strategic execution by agencies.

  • 01Pharmaceutical brands are using digital waiting rooms in telehealth platforms as premium ad slots.
  • 02New patient-attention data enhances pharma media plans for virtual care settings.
  • 03Virtual waiting rooms allow targeted patient engagement before and after healthcare consultations.

Aug 29, 2026

Roche pTau217 clearance and Labcorp’s Alzheimer’s test bring diagnostics to primary care

Roche pTau217 clearance and Labcorp’s Alzheimer’s test bring diagnostics to primary care

Recent advancements in Alzheimer’s pathology tests and lab automation are transforming diagnostics by moving the bottleneck from assay availability to workflow activation. These developments are making it feasible for primary care facilities to access cutting-edge diagnostic tools. This shift promises to enhance early detection and treatment strategies for Alzheimer's disease.

  • 01Lab automation is helping to remove bottlenecks in workflow activation for Alzheimer’s diagnostics.
  • 02Primary care facilities are gaining access to advanced Alzheimer’s diagnostic tests.
  • 03Early detection and treatment of Alzheimer's disease could be improved by these new diagnostic tools.

Aug 28, 2026

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech is investing $750 million in a new fill-finish plant in Hillsboro. The facility will focus on the production of prefilled syringes and autoinjectors. The site is expected to become operational in 2031.

  • 01Genentech is investing $750 million in a new Hillsboro facility.
  • 02The facility will produce prefilled syringes and autoinjectors.
  • 03Operations at the plant are expected to begin in 2031.

Aug 27, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512